Anavex
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Anavex and other ETFs, options, and stocks.About AVXL
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome.
CEOChristopher U. Missling
CEOChristopher U. Missling
Employees34
Employees34
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2004
Founded2004
Employees34
Employees34
AVXL Key Statistics
Market cap393.13M
Market cap393.13M
Price-Earnings ratio-8.18
Price-Earnings ratio-8.18
Dividend yield—
Dividend yield—
Average volume3.68M
Average volume3.68M
High today$4.52
High today$4.52
Low today$4.22
Low today$4.22
Open price$4.47
Open price$4.47
Volume1.08M
Volume1.08M
52 Week high$14.44
52 Week high$14.44
52 Week low$2.86
52 Week low$2.86
Stock Snapshot
With a market cap of 393.13M, Anavex(AVXL) trades at $4.44. The stock has a price-to-earnings ratio of -8.18.
During the trading session on 2025-12-05, Anavex(AVXL) shares reached a daily high of $4.52 and a low of $4.22. At a current price of $4.44, the stock is +5.2% higher than the low and still -1.8% under the high.
Trading activity shows a volume of 1.08M, compared to an average daily volume of 3.68M.
Over the past 52 weeks, Anavex(AVXL) stock has traded between a high of $14.44 and a low of $2.86.
Over the past 52 weeks, Anavex(AVXL) stock has traded between a high of $14.44 and a low of $2.86.
People also own
Based on the portfolios of people who own AVXL. This list is generated using Robinhood data, and it’s not a recommendation.